DNA Damage/DNA Repair
- MTH1(4)
- PARP(84)
- ATM/ATR(30)
- DNA Alkylating(20)
- DNA Ligases(3)
- DNA Methyltransferase(25)
- DNA-PK(30)
- HDAC(136)
- Nucleoside Antimetabolite/Analogue(140)
- Telomerase(17)
- Topoisomerase(151)
- tankyrase(5)
- Antifolate(38)
- CDK(250)
- Checkpoint Kinase (Chk)(31)
- CRISPR/Cas9(9)
- Deubiquitinase(72)
- DNA Alkylator/Crosslinker(71)
- DNA/RNA Synthesis(400)
- Eukaryotic Initiation Factor (eIF)(23)
- IRE1(23)
- LIM Kinase (LIMK)(9)
- TOPK(5)
- Casein Kinase(61)
- DNA Intercalating Agents(7)
- DNA/RNA Oxidative Damage(12)
Products for DNA Damage/DNA Repair
- Cat.No. Product Name Information
- GC65234 eIF4A3-IN-8 4-Hydroxybenzyl alcohol is a phenolic compound widely distributed in various kinds of plants. Anti-inflammatory, anti-oxidant, anti-nociceptive activity. Neuroprotective effect. Inhibitor of tumor angiogenesis and growth.
- GC64191 Elevenostat Elevenostat (JB3-22) is a selective HDAC11 inhibitor (IC50=0.235??M). Anti-multiple myeloma (MM) activity.
- GC25372 Elimusertib (BAY-1895344) hydrochloride Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.
- GC62108 Elimusertib hydrochloride Elimusertib (BAY 1895344) hydrochloride is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib hydrochloride has anti-tumor activity. Elimusertib hydrochloride can be used for the research of solid tumors and lymphomas.
- GC15548 Ellagic acid Casein kinase 2 (CK2) inhibitor
- GC15305 Ellipticine DNA topoisomerase II inhibitor
- GC35973 Ellipticine hydrochloride Ellipticine (NSC 71795) hydrochloride is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
- GC16044 Emodin Natural CK2 inhibitor and ER agonist
- GC11654 Enocitabine nucleoside analog used as chemotherapy
- GC34083 EOAI3402143 EOAI3402143 is a deubiquitinase (DUB) inhibitor, which inhibits dose-dependently inhibits Usp9x/Usp24 and Usp5.
-
GC43618
Epiblastin A
Epiblastin A is an ATP-competitive inhibitor of the casein kinase 1 (CK1) isoforms α, δ, and ε (IC50s = 8.9, 0.5, and 4.7 μM, respectively).
- GC35997 Epirubicin Epirubicin (4'-Epidoxorubicin), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase. Epirubicin inhibits DNA and RNA synthesis. Epirubicin is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity.
- GC35998 Episilvestrol Episilvestrol is a derivative of silvestrol, isolated from the fruits and twigs of Aglaia silvestris, and is a specific eIF4A-targeting translation inhibitor, with antitumor activity.
- GC61513 Epitalon TFA Epitalon TFA is an anti-aging agent and a telomerase activator.
- GC38102 Epithalon Epithalon is an anti-aging agent and a telomerase activator.
-
GC38103
Epithalon TFA
Epitalon TFA is an anti-aging agent and a telomerase activator.
- GC52516 Erbstatin A tyrosine kinase inhibitor
- GC48372 Erythromycin 2'-Propionate An antibiotic
- GC52303 Ethyl Mycophenolate A potential impurity found in commercial preparations of mycophenolate mofetil
- GC34112 Ethynylcytidine (ECyD) Ethynylcytidine (ECyD) (ECyD), a nucleoside analog and a potent inhibitor of RNA synthesis, inhibits RNA polymerases I, II and II. Ethynylcytidine (ECyD) has robust antitumor activity in a wide range of models of cancer.
-
GC15617
Etoposide
Topo II inhibitor
- GC60826 Etoposide phosphate Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands.
- GC10196 ETP-46464 ATR inhibitor,potent and selective
- GC38392 Euscaphic acid Euscaphic acid, a DNA polymerase inhibitor, is a triterpene from the root of the R. alceaefolius Poir. Euscaphic inhibits calf DNA polymerase α (pol α) and rat DNA polymerase β (pol β) with IC50 values of 61 and 108 μM. Euscaphic acid induces apoptosis.
- GC33108 Exatecan (DX-8951) Exatecan (DX-8951) (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
- GC62184 Exatecan D5 mesylate
- GC19148 Exatecan Mesylate Exatecan Mesylate is a water soluble topoisomerase I inhibitor, with an IC50 of 2.2 uM (0.975 ug/mL), and can be used in cancer research.
- GC62968 Fanotaprim Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC50s of 1.57 and 308 nM for tgDHFR (Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively.
- GC46146 FD-211 A δ lactone with anticancer activity
- GC16063 Flavopiridol An inhibitor of cyclin-dependent kinases
- GC16425 Flavopiridol hydrochloride CDK inhibitor, potent and selective
- GC18014 Floxuridine Antineoplastic antimetabolite
- GC14144 Fludarabine DNA synthsis inhibitor
- GC15134 Fludarabine Phosphate (Fludara) Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.
-
GC66430
Fludarabine triphosphate trisodium
Fludarabine triphosphate (F-ara-ATP) trisodium, the active metabolite of Fludarabine, is a potent, noncompetitive and specific inhibitor of DNA primase, with an IC50 of 2.3 μM and a Ki of 6.1 μM. Fludarabine triphosphate trisodium inhibits DNA synthesis by blocking DNA primase and primer RNA formation. Fludarabine triphosphate trisodium inhibits ribonucleotide reductase and DNA polymerase and ultimately leads to cellular apoptosis.
- GC16455 Flumequine DNA topoisomerase II inhibitor,synthetic chemotherapeutic antibiotic
- GC49134 Flumequine-13C3 An internal standard for the quantification of flumequine
- GC49455 Fluorescein-12-dATP A fluorescently labeled form of dATP
- GC49746 Fluorescein-12-dCTP A fluorescently labeled form of dCTP
- GC49456 Fluorescein-12-dGTP A fluorescently labeled form of dGTP
-
GC14466
Fluorouracil (Adrucil)
A prodrug form of FdUMP
- GC36062 FMF-04-159-2 FMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively.
- GC50719 FMF-04-159-R
- GC33049 FN-1501 FN-1501 is a potent inhibitor of FLT3 and CDK, with IC50s of 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively. FN-1501 has anticancer activity.
- GN10306 Folic acid
- GC63952 Folic Acid-d2 Folic Acid-d2 is the deuterium labeled Folic acid. Folic acid (Vitamin M; Vitamin B9) is a B vitamin; is necessary for the production and maintenance of new cells, for DNA synthesis and RNA synthesis.
- GC14331 Folinic acid NULL
- GC49126 Folitixorin A reduced form of folate and cofactor for thymidylate synthetase
- GC33029 Forodesine (BCX-1777 freebase) Forodesine (BCX-1777 freebase) (BCX-1777) is a highly potent and orally active purine nucleoside phosphorylase (PNP) inhibitor with IC50 values ranging from 0.48 to 1.57 nM for human, mouse, rat, monkey and dog PNP. Forodesine (BCX-1777 freebase) is a potent human lymphocyte proliferation inhibitor. Forodesine (BCX-1777 freebase) could induce apoptosis in leukemic cells by increasing the dGTP levels.
- GC32708 Forodesine hydrochloride (BCX-1777) Forodesine hydrochloride (BCX-1777) (BCX-1777 hydrochloride) is a highly potent and orally active purine nucleoside phosphorylase (PNP) inhibitor with IC50 values ranging from 0.48 to 1.57 nM for human, mouse, rat, monkey and dog PNP. Forodesine hydrochloride (BCX-1777) is a potent human lymphocyte proliferation inhibitor. Forodesine hydrochloride (BCX-1777) could induce apoptosis in leukemic cells by increasing the dGTP levels.
- GC14885 Foscarnet Sodium Reverse transcriptase inhibitor
- GC36071 Fosteabine Fosteabine is an oral and prodrug analogue of cytarabine which is resistant to deoxycytidine deaminase.
- GC64005 FPFT-2216 FPFT-2216, a “molecular glue” compound, degrades phosphodiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3), and casein kinase 1α (CK1α).
- GC13831 FT-207 (NSC 148958) FT-207 (NSC 148958) (FT 207; NSC 148958) is a chemotherapeutic 5-FU prodrug used in the treatment of cancers; is a component of tegafur-uracil.
- GC62979 FT206 FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1.
- GC67915 FT3967385
- GC32786 FT671 FT671 is a potent, non-covalent and selective USP7 inhibitor with an IC50 of 52 nM and binds to the USP7 catalytic domain with a Kd of 65 nM.
-
GC69134
FT709
FT709 is an effective selective inhibitor of USP9X with an IC50 value of 82 nM. USP9X is involved in centrosome function, chromosome alignment during mitosis, EGF receptor degradation, chemical sensitization and circadian rhythms.
- GC32917 FT827 FT827 is a selective and covalent ubiquitin-specific protease 7 (USP7) inhibitor (Ki=4.2 ?M). FT827 binds to the USP7 catalytic domain (USP7CD; residues 208-560) with an apparent Kd value of 7.8 ?M.
- GC65206 FT895 FT895 is a potent and selective HDAC11 inhibitor with an IC50 of 3 nM.
- GC13541 G007-LK tankyrase 1/2 inhibitor
-
GC43726
Gallotannin
Gallotannin is a polyphenol of gallic acid that has been found in various plants and has antioxidant, anti-inflammatory, antiviral, and antiproliferative biological activities.
- GC60865 Ganciclovir sodium Ganciclovir (BW 759) sodium, a nucleoside analogue, is an orally active antiviral agent with activity against CMV.
- GN10696 Garcinone C
- GC14376 Gatifloxacin Fluoroquinolone antibiotic,inhibits bacterial TOPO II
- GC33094 GC7 Sulfate GC7 Sulfate is a deoxyhypusine synthase (DHPS) inhibitor.
- GC32739 GCN2iB GCN2iB is an ATP-competitive inhibitor of a serine/threonine-protein kinase general control nonderepressible 2 (GCN2), with an IC50 of 2.4 nM.
- GC62986 GDC-0425 GDC-0425 (RG-7602) is an orally available, highly selective small molecule ChK1 inhibitor. GDC-0425 can be used for the research of various malignancies.
- GC32885 GDC-0575 (ARRY-575, RG7741) GDC-0575 (ARRY-575, RG7741) (ARRY-575, RG7741) is a highly-selective oral small-molecule Chk1 inhibitor with an IC50 of 1.2nM.
- GC34127 GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) (ARRY-575 dihydrochloride) is an orally bioavailable CHK1 inhibitor, with an IC50 of 1.2 nM, and has antitumor activity.
-
GC19542
GeA-69
GeA-69 is a selective, highly cell permeable allosteric inhibitor
-
GC16805
Gemcitabine
An inhibitor of DNA synthesis
- GC36130 Gemcitabine elaidate A prodrug form of gemcitabine
- GC63777 Gemcitabine elaidate hydrochloride Gemcitabine elaidate (CP-4126) hydrochloride is lipophilic pro-drug of Gemcitabine. Gemcitabine elaidate hydrochloride is converted to Gemcitabine by esterases in order to be phosphorylated. Gemcitabine elaidate hydrochloride exhibits anti-tumor activity.
- GC14447 Gemcitabine HCl Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis.
- GC14102 Genistein Genistein is an isoflavone belonging to the flavonoid group of compounds and is found in a number of plants.
- GC15853 Genz-644282 An inhibitor of topoisomerase I
- GC32088 Gepotidacin (GSK2140944) Gepotidacin (GSK2140944) (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.
- GC64926 GFB-12811 GFB-12811 is a high selective and orally active CDK5 inhibitor with an IC50 of 2.3 nM.
- GC18840 Gilvocarcin V Gilvocarcin V is an antitumor antibiotic with a coumarin-based aromatic structure that was orignally isolated from the culture broth of S.
- GC60873 Gimatecan Gimatecan (ST1481) is a potent topoisomerase I inhibitor. Gimatecan is an orally bioavailable camptothecin analogue with antitumor activity.
- GC33050 Givinostat (ITF-2357) Givinostat (ITF-2357) (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.
- GC33159 Givinostat hydrochloride (ITF-2357 hydrochloride) Givinostat (ITF-2357) hydrochloride is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.
- GC36153 Glucose-conjugated MGMT inhibitor Glucose-conjugated MGMT inhibitor is a potent O6-methylguanine-DNAmethyl-transferase (MGMT) inhibitor, with IC50s of 32 nM in vitro (cell extracts) and 10 nM in HeLa S3 cells.
- GC30529 GNE-371 GNE-371 is a potent and selective chemical probe for the second bromodomains of human transcription-initiation-factor TFIID subunit 1 and transcription-initiation-factor TFIID subunit 1-like, with an IC50 of 10 nM for TAF1(2).
- GC32856 GNE-6640 An inhibitor of USP7
- GC32727 GNE-6776 GNE-6776 is a selective and orally bioavailable USP7 inhibitor.
- GC39172 GRL0617 A SARS-CoV and SARS-CoV-2 PLpro inhibitor
- GC38511 Groenlandicine Groenlandicine is a protoberberine alkaloid isolated from Coptidis Rhizoma.
- GC14987 GSK-3 Inhibitor IX (BIO) GSK-3 Inhibitor IX (BIO) (6-Bromoindirubin-3'-oxime; BIO) is a potent, selective, reversible and ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex with IC50s of 5 nM/320 nM/80 nM for (GSK-3α/β)/CDK1/CDK5, respectively.
- GC62423 GSK-3/CDK5/CDK2-IN-1 GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, and GSK-3 extracted from patent WO2002010141A1, example 9a.
- GC34354 GSK2643943A GSK2643943A is a deubiquitinating enzyme (DUB) inhibitor targeting USP20. GSK2643943A has affinity with an IC50 of 160 nM for USP20/Ub-Rho. GSK2643943A has anti-tumor efficacy and can be used for the research of oral squamous cell carcinoma (OSCC) .
- GC32857 GSK2850163 GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit IRE1α kinase activity and RNase activity with IC50s of 20 and 200 nM, respectively.
- GC34205 GSK2850163 hydrochloride GSK2850163 hydrochloride is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit IRE1α kinase activity and RNase activity with IC50s of 20 and 200 nM, respectively.
- GC18402 GSK3117391 GSK3117391 is a histone deacetylase (HDAC) inhibitor, extracted from patent WO/2008040934 A1.
- GC36196 Guadecitabine sodium Guadecitabine is a novel hypomethylating dinucleotide of decitabine and deoxyguanosine that is resistant to degradation by cytidine deaminase.
- GC16949 Guanine A purine base
- GC49033 Guanosine 5’-diphosphate (sodium salt hydrate) A purine nucleotide
- GC43798 Guanylyl Imidodiphosphate (lithium salt) Guanylyl imidodiphosphate (Gpp(NH)p) lithium, a non-hydrolyzable GTP analogue, increases adenylate cyclase activity.
- GC31650 Halofuginone (RU-19110) Halofuginone (RU-19110) (RU-19110), a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM.